Lu W, Zeng S, Yao Y, Luo Y, Ruan T
Front Public Health. 2024; 12:1338208.
PMID: 38660347
PMC: 11041831.
DOI: 10.3389/fpubh.2024.1338208.
Rahman M, Kamigaki T, Thandar M, Haruyama R, Yan F, Shibamura-Fujiogi M
BMJ Open. 2023; 13(12):e076892.
PMID: 38128943
DOI: 10.1136/bmjopen-2023-076892.
Almendares O, Ruffin J, Collingwood A, Nolen L, Lanier W, Dash S
Pediatrics. 2023; 152(6).
PMID: 37960897
PMC: 11247457.
DOI: 10.1542/peds.2023-062422.
Song S, Madewell Z, Liu M, Longini I, Yang Y
Front Public Health. 2023; 11:1195908.
PMID: 37361171
PMC: 10289159.
DOI: 10.3389/fpubh.2023.1195908.
Spicer K, Glick C, Thoroughman D
J Adolesc Health. 2023; 73(3):536-542.
PMID: 37318408
PMC: 10176104.
DOI: 10.1016/j.jadohealth.2023.04.032.
Evaluation of Waning of SARS-CoV-2 Vaccine-Induced Immunity: A Systematic Review and Meta-analysis.
Menegale F, Manica M, Zardini A, Guzzetta G, Marziano V, dAndrea V
JAMA Netw Open. 2023; 6(5):e2310650.
PMID: 37133863
PMC: 10157431.
DOI: 10.1001/jamanetworkopen.2023.10650.
A new set-up of vanishing antibodies: A biennial follow-up of five different clients' humoral responses against SARS-CoV-2 after systemic vaccination in an oncology hospital in Poland.
Kosiorek P, Stroz S, Hryniewicz A, Kazberuk D, Milewski R, Bartoszewicz K
Health Sci Rep. 2023; 6(4):e1172.
PMID: 37008810
PMC: 10064024.
DOI: 10.1002/hsr2.1172.
Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review.
Haque M, Tanbir M, Ahamed B, Hossain M, Roy A, Shahriar M
Clin Pathol. 2023; 16:2632010X231161222.
PMID: 36938514
PMC: 10014419.
DOI: 10.1177/2632010X231161222.
Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years.
Oliveira E, Oliveira M, Simoes E Silva A, Colosimo E, Mak R, Vasconcelos M
World J Pediatr. 2023; 19(10):949-960.
PMID: 36914907
PMC: 10010648.
DOI: 10.1007/s12519-023-00699-6.
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529).
Mohammed H, Pham-Tran D, Yeoh Z, Wang B, McMillan M, Andraweera P
Vaccines (Basel). 2023; 11(2).
PMID: 36851102
PMC: 9965204.
DOI: 10.3390/vaccines11020224.
Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
Buchan S, Alley S, Seo C, Johnson C, Kwong J, Nasreen S
JAMA Pediatr. 2023; 177(4):410-418.
PMID: 36848096
PMC: 9972235.
DOI: 10.1001/jamapediatrics.2022.6166.
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12-17 Years, by Dosing Interval and Duration.
Ionescu I, Skowronski D, Sauvageau C, Chuang E, Ouakki M, Kim S
J Infect Dis. 2023; 227(9):1073-1083.
PMID: 36645782
PMC: 10132765.
DOI: 10.1093/infdis/jiad006.
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
Castelli J, Rearte A, Olszevicki S, Voto C, Juarez M, Pesce M
BMJ. 2022; 379:e073070.
PMID: 36450402
PMC: 9709697.
DOI: 10.1136/bmj-2022-073070.
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.
He X, Su J, Ma Y, Zhang W, Tang S
Front Immunol. 2022; 13:945930.
PMID: 36090988
PMC: 9459021.
DOI: 10.3389/fimmu.2022.945930.
Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period.
Florentino P, Alves F, Cerqueira-Silva T, Oliveira V, Junior J, Jantsch A
Nat Commun. 2022; 13(1):4756.
PMID: 35963844
PMC: 9375192.
DOI: 10.1038/s41467-022-32524-5.
